De‐Shen Wang
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Oncology top 1%
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 75
- Colorectal Cancer Treatments and Studies 25
- Pancreatic and Hepatic Oncology Research 14
- Inflammatory Biomarkers in Disease Prognosis 10
-
- Gastric Cancer Management and Outcomes 25
- Co-authors
- Rui‐Hua Xu (82 shared papers)Huai‐Qiang Ju (16 shared papers)Yuhong Li (59 shared papers)Miao‐Zhen Qiu (37 shared papers)Hui Luo (36 shared papers)Zerong Cai (2 shared papers)Jia Liu (1 shared paper)Dong-sheng Zhang (23 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Medicine (5 papers)Tumor Biology (5 papers)Journal of Translational Medicine (5 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
De‐Shen Wang
140 papers receiving 6.1k citations
De‐Shen Wang's Hit Papers
Peers
Comparison fields: 5 of 159
- Cancer Research 2.5k
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 2.9k
- Pathology and Forensic Medicine 547
Countries citing papers authored by De‐Shen Wang
This map shows the geographic impact of De‐Shen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De‐Shen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De‐Shen Wang more than expected).
Fields of papers citing papers by De‐Shen Wang
This network shows the impact of papers produced by De‐Shen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De‐Shen Wang. The network helps show where De‐Shen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside De‐Shen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circular RNA: metabolism, functions and interactions with proteins Hit paper breakdown → | 2020 | 848 |
| 2 | A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma Hit paper breakdown → | 2020 | 413 |
| 3 | LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer Hit paper breakdown → | 2019 | 374 |
| 4 | 2016 | 216 | |
| 5 | 2012 | 194 | |
| 6 | 2015 | 140 | |
| 7 | 2018 | 138 | |
| 8 | 2018 | 134 | |
| 9 | 2013 | 129 | |
| 10 | 2013 | 118 | |
| 11 | 2021 | 116 | |
| 12 | 2017 | 110 | |
| 13 | 2014 | 109 | |
| 14 | 2021 | 108 | |
| 15 | 2011 | 105 | |
| 16 | 2011 | 97 | |
| 17 | 2012 | 94 | |
| 18 | 2018 | 84 | |
| 19 | 2020 | 79 | |
| 20 | 2007 | 75 |
About De‐Shen Wang
De‐Shen Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 142 papers that have together received 6.2k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (25 papers), Colorectal Cancer Treatments and Studies (25 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Cancer Genomics and Diagnostics (11 papers), Genetic factors in colorectal cancer (10 papers) and Inflammatory Biomarkers in Disease Prognosis (10 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.4k citations), Molecular Biology (2.9k citations) and Pathology and Forensic Medicine (547 citations). De‐Shen Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Rui‐Hua Xu, Huai‐Qiang Ju, Yuhong Li, Miao‐Zhen Qiu, Hui Luo, Zerong Cai, Jia Liu, Dong-sheng Zhang, Zhao-Lei Zeng and Chao Ren. Their work appears in journals such as Journal of Clinical Oncology, Cancer Medicine, Tumor Biology, Journal of Translational Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.